HIV/AIDS Monitoring and Evaluation Systems Strengthening for the National AIDS Program in Albania

Klodian Rjepaj1, Roland Bani1

  • 1Institute of Public health, Tirana, Albania.

Materia Socio-Medica
|February 11, 2014
PubMed

The Institute of Public Health (IPH) is the Principal Recipient (PR) of the Global Fund for AIDS, TB and Malaria Round 5 HIV/AIDS and TB grants. The GF HIV Grant is highly targeted, aimed at filling key gaps in the national response to HIV/AIDS. Albania is considered a low HIV prevalence country based on the number of reported cases. The work presented in this paper is carried out as part of the Monitoring and evaluation framework development in respect to the National AIDS strategy and Global Fund agreement. The performance framework consists of a range of indicators agreed by the PR (IPH in Albania), and specific targets to be met on an annual base. The PR must, therefore, be able to measure its performance against this framework in order to demonstrate that it is meeting its targets. To assist this process, the GFATM requires PRs to undertake an assessment of their capacity to monitor and evaluate the program, and put in place measures to strengthen any identified weaknesses. The Global Fund's M&E Systems Strengthening Tool, MESST, was used. The MESST is conducted via a participatory workshop involving the PR, SRs,(Subrecipients) some representatives of the Country Coordinating Mechanism (CCM), the donor community and other stakeholders or implementing partners relevant to the exercise. The proposed output for this exercise is an M&E Action Plan for the PR. A 2-day MESST workshop was held in Tirana, Albania. Participants at the workshop assessed the M&E capacity of the national HIV program, and its implementers, the IPH and the sub recipients (SRs), by looking at three elements of the M&E system. These are: The Monitoring and Evaluation Plan, The ability of collate and analyze data at the IPH, The reporting systems in the health facilities, the community and the laboratories, The result was identification of a range of strengths and weaknesses, and from these, the development of a list of key actions to address the weaknesses identified.

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
853
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342